Abstract

Since its first detection in 1979, dengue fever has been considered a major public health issue in the Lao People’s Democratic Republic (PDR). Dengue virus (DENV) serotype 1 was the cause of an epidemic in 2010–2011. Between 2012 and 2020, major outbreaks due successively to DENV-3, DENV-4 and recently DENV-2 have been recorded. However, DENV-1 still co-circulated in the country over this period. Here, we summarize epidemiological and molecular data of DENV-1 between 2016 and 2020 in the Lao PDR. Our data highlight the continuous circulation of DENV-1 in the country at levels ranging from 16% to 22% among serotyping tests. In addition, the phylogenetic analysis has revealed the circulation of DENV-1 genotype I at least since 2008 with a co-circulation of different clusters. Sequence data support independent DENV-1 introductions in the Lao PDR correlated with an active circulation of this serotype at the regional level in Southeast Asia. The maintenance of DENV-1 circulation over the last ten years supports a low level of immunity against this serotype within the Lao population. Thereby, the risk of a DENV-1 epidemic cannot be ruled out in the future, and this emphasizes the importance of maintaining an integrated surveillance approach to prevent major outbreaks.

Highlights

  • Dengue viruses (DENVs) are the most prevalent human arboviruses worldwide as a direct consequence of the distribution of the main dengue viruses’ vector Aedes species (Aedes aegypti, Aedes albopictus) [1]

  • Epidemiological studies in the Lao People’s Democratic Republic (PDR) revealed a cascade of epidemics due to a rapid switch in the predominance of DENV serotypes (Figure 1)

  • A successive predominance of DENV-3, DENV-4 and DENV-2 was observed in the Lao PDR, as previously described [18]

Read more

Summary

Introduction

Dengue viruses (DENVs) are the most prevalent human arboviruses worldwide as a direct consequence of the distribution of the main dengue viruses’ vector Aedes species (Aedes aegypti, Aedes albopictus) [1]. In 2019, 4.2 million dengue cases were reported by the. World Health Organization (WHO), with 70% of the burden in Asia. The global surge in dengue between 2000 and 2015 was accompanied by more than a 4-fold increase in the number of reported deaths [2]. DENV are positive-sense RNA viruses (Flavivirus genus; Flaviviridae family) of which four distinct serotypes were identified (DENV-1 to DENV-4) [3,4,5,6]. DENV-1 was first detected in 1943 in French Polynesia and Japan and seemed to be the most reported serotype between 1943 and 2013 [7,8]. Five DENV-1 genotypes are currently described: genotype I (Asia), II (Thailand), III (Malaysia), IV (South Pacific) and V (America/Africa) [10,11]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call